CAS 1014405-03-8

Oxocarbazate

CAS: 1014405-03-8

Oxocarbazate (CID23631927) is a subnanomolar, reversible cathepsin L inhibitor, also reducing SARS-CoV and Ebola virus entry into human cells.

Fórmula: C₂₈H₃₃N₅O₆

Forma y color: Solid

Peso molecular: 535.59

Ref: TM-T71618

Oxocarbazate

CAS: 1014405-03-8

Oxocarbazate is a potent anticancer drug that acts as an analog of the protein kinase inhibitor, staurosporine. It has been found to induce apoptosis in tumor cells and inhibit cell cycle progression. Oxocarbazate is a promising medicinal compound for the treatment of cancer, as it has shown to be effective against human cancer cell lines. This inhibitor has also displayed significant anti-tumor activity in Chinese hamster ovary cells, making it a potential candidate for cancer therapy. Furthermore, oxocarbazate has been detected in urine samples from patients undergoing chemotherapy, suggesting its potential use in clinical settings.

Fórmula: C₂₈H₃₃N₅O₆

Pureza: Min. 95%

Forma y color: Powder

Peso molecular: 535.6 g/mol

Ref: 3D-PQB40503